STRS Ohio’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-43,300
Closed -$50K 2157
2023
Q1
$50K Buy
43,300
+2,300
+6% +$4.21K ﹤0.01% 1787
2022
Q4
$109K Buy
41,000
+15,400
+60% +$40.6K ﹤0.01% 1716
2022
Q3
$73K Hold
25,600
﹤0.01% 1788
2022
Q2
$127K Hold
25,600
﹤0.01% 1711
2022
Q1
$182K Buy
25,600
+23,700
+1,247% +$196K ﹤0.01% 1727
2021
Q4
$34K Hold
1,900
﹤0.01% 2058
2021
Q3
$37K Buy
+1,900
New +$72.3K ﹤0.01% 2112

Other funds holding CELL

STRS Ohio's CELL Position: Q2 2023 in Review

STRS Ohio sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 43,300 shares — an estimated $50K sold.

STRS Ohio first reported a position in CELL in Q3 2021 and held it in 7 quarters. The position peaked at $182K in Q1 2022. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • STRS Ohio reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • STRS Ohio sold 43,300 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $50K.
  • STRS Ohio first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • STRS Ohio's PhenomeX Inc. Common Stock position peaked at $182K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.